Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Spiera

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
NEJM Evidence|June 3, 2026
Secukinumab for Giant Cell ArteritisJohn H Stone, Nils Venhoff, Frank Buttgereit, et al.
The American Journal of Medicine|July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosisJavier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Arthritis and Rheumatism|June 3, 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase diseaseArnold E Postlethwaite, Weng Kee Wong, Philip Clements, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAndreas Kronbichler, Johannes Leierer, Jae Il Shin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2014
Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitisSebastian Unizony, Noha Lim, Deborah J Phippard, et al.
Plos One|January 27, 2012
Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitisPaul A Monach, Philipp Kümpers, Alexander Lukasz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2017
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell ArteritisCarol A Langford, David Cuthbertson, Steven R Ytterberg, et al.
The New England Journal of Medicine|June 3, 2026
Phase 3 Trial of Secukinumab in Polymyalgia RheumaticaJohn H Stone, Frank Buttgereit, Alain Saraux, et al.
Arthritis Care & Research|September 29, 2011
Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's)Gunnar Tomasson, Maarten Boers, Michael Walsh, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
NEJM Evidence|June 3, 2026
Secukinumab for Giant Cell ArteritisJohn H Stone, Nils Venhoff, Frank Buttgereit, et al.
The American Journal of Medicine|July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosisJavier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Arthritis and Rheumatism|June 3, 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase diseaseArnold E Postlethwaite, Weng Kee Wong, Philip Clements, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAndreas Kronbichler, Johannes Leierer, Jae Il Shin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2014
Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitisSebastian Unizony, Noha Lim, Deborah J Phippard, et al.
Plos One|January 27, 2012
Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitisPaul A Monach, Philipp Kümpers, Alexander Lukasz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2017
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell ArteritisCarol A Langford, David Cuthbertson, Steven R Ytterberg, et al.
The New England Journal of Medicine|June 3, 2026
Phase 3 Trial of Secukinumab in Polymyalgia RheumaticaJohn H Stone, Frank Buttgereit, Alain Saraux, et al.
Arthritis Care & Research|September 29, 2011
Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's)Gunnar Tomasson, Maarten Boers, Michael Walsh, et al.
Pageof 10